Stabilization of nucleic acids on paper
The present invention and embodiments thereof relates to compositions and methods for storage, stabilization and preservation of biological samples and/or nucleic acids on a solid matrix. Methods for extracting, collecting, and recovering the biological samples and/or nucleic acids from the solid matrix are also described.
1. A solid matrix for storing a biological sample, comprising:
a matrix material that is a non-dissolvable dry solid material;
a buffer impregnated in the matrix material in a substantially dry state or a dry state; and
at least one reducing agent and at least one antioxidant, but no denaturant or chelator;
wherein the biological sample comprises one or more nucleic acids.
2. The solid matrix of claim 1 , wherein the at least one reducing agent is impregnated in the matrix material in a substantially dry state.
3. The solid matrix of claim 2 , wherein the at least one reducing agent is dithiothreitol (DTT), 2-mercaptoethanol (2-ME), 2-mercaptoethylamine, or cysteine.
4. The solid matrix of claim 1 , wherein the at least one antioxidant is impregnated in the matrix material in a substantially dry state.
5. The solid matrix of claim 4 , wherein the at least one antioxidant is hydroquinone monomethyl ether (MEHQ), hydroquinone (HQ), or toluhydroquinone (THQ).
6. The solid matrix of claim 1 , wherein the non-dissolvable dry solid material is a cellulosic paper.
7. The solid matrix of claim 1 , wherein the buffer is selected from citric acid, tris(2-carboxyethyl)phosphine hydrochloride (TCEP-HCl), oxidized form of tris(2-carboxyethyl)phosphine hydrochloride (TCEPO-HCl), 2-amino-2-hydroxymethyl-propane-1,3-diol (Tris), 2-(N-morpholino)ethanesulfonic acid (MES), 3-(N-morpholino)propanesulfonic acid (MOPS), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), phosphate buffers, acetic acid, ascorbic acid, sulfosalicylic acid, formic acid, glycine, glycine-glycine, malic acid, and succinic acid.
8. The solid matrix of claim 1 , wherein the buffer has a pH of 2.0 to 8.0.
9. The solid matrix of claim 1 , wherein the biological sample is blood, serum, plasma, tissue, saliva, cells, synovial fluids, urine, or semen.
10. A method for storing one or more biological samples, the method comprising:
contacting the solid matrix of claim 1 with a biological sample, wherein the biological sample comprises one or more nucleic acids;
drying the solid matrix containing the biological sample; and
storing the biological sample on the solid matrix in a substantially dry state or a dry state.
11. The method of claim 10 , further comprising recovering the biological sample from the solid matrix.
12. The method of claim 11 , further comprising extracting the nucleic acids from the biological sample.
13. The method of claim 10 , wherein the nucleic acids are extracted from the biological sample and stored on the solid matrix in a substantially dry state or a dry state.
14. The method of claim 13 , further comprising recovering the nucleic acids from the solid matrix.
15. The method of claim 10 , wherein the non-dissolvable dry solid material is a cellulosic paper.
16. The method of claim 10 , wherein the buffer is selected from citric acid, tris(2-carboxyethyl)phosphine hydrochloride (TCEP-HCl), oxidized form of tris(2-carboxyethyl)phosphine hydrochloride (TCEPO-HCl), 2-amino-2-hydroxymethyl-propane-1,3-diol (Tris), 2-(N-morpholino)ethanesulfonic acid (MES), 3-(N-morpholino)propanesulfonic acid (MOPS), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), phosphate buffers, acetic acid, ascorbic acid, sulfosalicylic acid, formic acid, glycine, glycine-glycine, malic acid, and succinic acid.
17. The method of claim 10 , wherein the buffer has a pH of 2.0 to 8.0.
18. The method of claim 10 , wherein the biological sample is blood, serum, plasma, tissue, saliva, cells, synovial fluids, urine, or semen.
19. The method of claim 10 , wherein the nucleic acids are RNA.
20. The method of claim 10 , wherein the nucleic acids are virus RNA.